Vedana Therapeutics

Seattle, United States

Vedana Therapeutics is a Seattle biotechnology company developing next-generation antibody therapies for migraine prevention.

Jun 2026

Series A

Biotechnology Medical Pharmaceutical

Top Investors

Canaan PartnersWestlake Village BioPartnersAlexandria Venture InvestmentsDawn Biopharma

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Vedana Therapeutics

Who are Vedana Therapeutics's investors?

Vedana Therapeutics's investors include Canaan Partners, Westlake Village BioPartners, Alexandria Venture Investments, Dawn Biopharma.

Where is Vedana Therapeutics headquartered?

Vedana Therapeutics is headquartered in Seattle, United States.

What does Vedana Therapeutics do?

Vedana Therapeutics is a Seattle biotechnology company developing next-generation antibody therapies for migraine prevention.

What stage is Vedana Therapeutics at?

Vedana Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 17, 2026.

MLA

"Vedana Therapeutics — Funding & Investors." VCBacked, June 17, 2026, https://www.vcbacked.co/company/vedana-therapeutics. Accessed June 30, 2026.

APA

VCBacked. (2026). Vedana Therapeutics — Funding & Investors. Retrieved June 30, 2026, from https://www.vcbacked.co/company/vedana-therapeutics

Wikipedia (cite web)

{{cite web |title=Vedana Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/vedana-therapeutics |website=VCBacked |access-date=June 30, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 17, 2026.

Similar Companies in Biotechnology